Coronary artery anomalies: contemporary approaches to risk stratification and management

Flavio Giuseppe Biccirè1,2, Dario Mafrica2,3, Matteo Mancinelli2

  • 1Cardiovascular Sciences Department, San Giovanni Addolorata Hospital, via dell'Amba Aradam, 8, 00184 Rome, Italy.

Insights

Coronary artery anomalies, like anomalous aortic origin of a coronary artery (AAOCA), are increasingly found with CCTA. Most adult AAOCA cases are benign, and CCTA can help guide clinical decisions.

Area of Science:

  • Cardiovascular Imaging
  • Interventional Cardiology
  • Radiology

Background:

  • Coronary computed tomography angiography (CCTA) is increasingly detecting coronary artery anomalies, particularly anomalous aortic origin of a coronary artery (AAOCA).
  • AAOCA is debated due to historical associations with ischemia and sudden cardiac death, yet often found incidentally in asymptomatic adults.
  • Current evidence suggests many adult AAOCA cases have a benign course, challenging anatomy-based risk stratification alone.

Purpose of the Study:

  • To review current evidence on coronary artery anomalies, focusing on AAOCA.
  • To propose a pragmatic approach for clinical decision-making in AAOCA management.
  • To highlight the role of CCTA in assessing AAOCA and guiding further testing.

Main Methods:

  • Review of current literature on coronary artery anomalies and AAOCA.
  • Emphasis on the diagnostic capabilities of CCTA for defining coronary anatomy and morphology.
  • Discussion of integrating anatomical findings with functional assessments when necessary.

Main Results:

  • CCTA accurately defines coronary origin, course, and morphology, aiding in AAOCA detection.
  • Quantitative CCTA parameters can help exclude hemodynamically significant AAOCA, reducing unnecessary invasive procedures.
  • Most adult AAOCA cases are not associated with significant ischemia and follow a benign clinical course.

Conclusions:

  • Anatomical assessment alone is insufficient for risk stratification in AAOCA.
  • CCTA plays a crucial role in characterizing AAOCA and assessing atherosclerotic disease.
  • A stepwise approach combining anatomical and functional assessments is recommended for managing AAOCA.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...